Markets:

Overview

News

Currencies

International

Treasuries

Dynavax Technologies Corporation - Common Stock (NQ:DVAX)

15.50 UNCHANGED

Last Price Updated: 4:00 PM EST, Feb 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Dynavax Technologies Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Dynavax Technologies: Q2 Earnings Insights ↗

August 04, 2022

Dynavax Technologies (NASDAQ:DVAX) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Keep Amphastar Pharmaceuticals Stock On Your Watch List Ahead Of Earnings ↗

July 26, 2022

IBD 50 member Amphastar Pharmaceuticals stock is expected to report on Aug. 9 and is trading approximately 12% below a 42.41 entry.

Via Investor's Business Daily

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 25, 2022

Gainers

Via Benzinga

Crispr Therapeutics Stock Shows Rising Price Performance With Jump To 94 RS Rating ↗

July 15, 2022

Crispr Therapeutics sees its Relative Strength Rating enter the elite 90-plus level.

Via Investor's Business Daily

Biotech Hasn't Been This Blazing Hot Since Early 2021 — Here Are The Top 5 ↗

July 15, 2022

The group has several commonalities, including strong ratings and promising charts.

Via Investor's Business Daily

Earnings Scheduled For February 28, 2022 ↗

February 28, 2022

Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (...

Via Benzinga

Prometheus Biosciences Stock Shows Rising Relative Strength ↗

July 14, 2022

Prometheus Biosciences stock saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, with an increase from 72 to 90.

Via Investor's Business Daily

Merus Stock Joins Rank Of Stocks With RS Ratings Over 90 ↗

July 14, 2022

On Thursday, Netherlands-based Merus stock had its Relative Strength (RS) Rating upgraded to 94 from 78 a day earlier.

Via Investor's Business Daily

Apellis Pharmaceuticals Stock Scores Relative Strength Rating Upgrade ↗

July 13, 2022

ApellisPharmaceuticals sees its Relative Strength Rating reach the elite 90-plus level.

Via Investor's Business Daily

Vir Biotechnology Stock Joins Rank Of Stocks With RS Ratings Over 90 ↗

July 11, 2022

On Monday, Vir Biotechnology stock had its Relative Strength (RS) Rating upgraded to 91 Monday, up from 85 a day earlier.

Via Investor's Business Daily

Uniqure Stock Sees Healthy Price Gain, Ranks Among Top 8% ↗

July 11, 2022

Among its other key ratings, Amsterdam-based gene therapy company Uniqure stock also has a 92 Composite Rating.

Via Investor's Business Daily

Kezar Life Sciences Stock Shows Rising Market Leadership: Earns 81 RS Rating ↗

July 08, 2022

The Relative Strength (RS) Rating for Kezar Life Sciences stock jumped into a new percentile Friday, with a rise from 78 to 81.

Via Investor's Business Daily

Apellis Pharmaceuticals Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating ↗

July 08, 2022

Apellis Pharmaceuticals stock saw its Relative Strength (RS) Rating upgraded to 85 Friday, up from 79 a day earlier.

Via Investor's Business Daily

7 Small-Cap Stocks to Buy in July 2022 ↗

July 04, 2022

These are the best small-cap stocks to buy for July 2022. ARCH, AVUV, CEIX, COUR, DVAX, FATE, and TENB can make great investments.

Via InvestorPlace

56 Stocks Moving In Friday's Mid-Day Session ↗

May 13, 2022

Gainers Veru Inc. (NASDAQ: VERU) shares jumped 62.5% to $14.67 after the company reported quarterly results on Thursday. Jefferies maintained Veru with a Buy and raised the price target from $33 to...

Via Benzinga

110 Biggest Movers From Friday ↗

May 16, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 12, 2022

Gainers

Via Benzinga

Dynavax's Adjuvant-Based Bivalent COVID-19 Vaccine Candidate Shows Encouraging Preclinical Action ↗

May 05, 2022

Via Benzinga

Dynavax Adjuvanted Clover Bio's COVID-19 Vaccine Booster Shows Durable Protection Against Omicron ↗

March 17, 2022

Via Benzinga

The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data ↗

March 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Recap: Dynavax Technologies Q4 Earnings ↗

February 28, 2022

Dynavax Technologies (NASDAQ:DVAX) reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement....

Via Benzinga

A Preview Of Dynavax Technologies's Earnings ↗

February 25, 2022

Dynavax Technologies (NASDAQ:DVAX) is set to give its latest quarterly earnings report on Monday, 2022-02-28. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

Three doses of Valneva's COVID-19 Vaccine Neutralizes Omicron Variant, Lab Study Shows ↗

January 19, 2022

Valneva SE (NASDAQ: VALN) has announced results from an initial laboratory study demonstrating that serum antibodies induced by three doses of Valneva's COVID-19 vaccine...

Via Benzinga

10 Biggest Price Target Changes For Wednesday ↗

December 29, 2021

Tigress Financial lifted the price target on McDonald's Corporation (NYSE:

Via Benzinga

Here's Why These 3 COVID-19 Vaccine Stocks Got Crushed This Week ↗

December 03, 2021

These second-tier COVID-19 vaccine players plunged due to fears about the potential impacts of the omicron variant.

Via The Motley Fool

Why Dynavax Stock Is Tumbling Today ↗

December 03, 2021

The biotech stock is being pulled down by the broader market sell-off.

Via The Motley Fool

Why Are Valneva Shares Trading Higher Today? ↗

November 23, 2021

Valneva SE (NASDAQ: VALN) has signed an Advance Purchase Agreement (APA) with the European Commission (EC) to supply up to 60 million doses of its inactivated COVID...

Via Benzinga

2 Top Stocks You Can Still Buy for Under $20 a Share ↗

November 12, 2021

These two stocks have more than doubled in 2021, but they still can be bought for under $20 per share.

Via The Motley Fool

Valneva Shares Soar On Securing EU COVID-19 Vaccine Deal ↗

November 10, 2021

Valneva SE (NASDAQ: VALN) shares jumped more than 20% after winning approval from the European Commission for a deal. Over two years, the Company would supply up...

Via Benzinga

92 Biggest Movers From Friday ↗

November 08, 2021

Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares jumped 99.8% to close at $9.99 on Friday. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.